ICH M13B Webinar: Navigating the Draft ICH M13B Additional Strengths Biowaiver Guideline September 11, 2025

https://www.fda.gov/drugs/news-events-human-drugs/ich-m13b-webinar-navigating-draft-ich-m13b-additional-strengths-biowaiver-guideline-09112025?utm_medium=email&utm_source=govdelivery ICH M13B Webinar: Navigating the Draft ICH M13B Additional Strengths Biowaiver Guideline Date: Thu, Sept. 11, 2025; noon - 2 p.m. ET This webinar will provide an in-depth look at the draft ICH M13B guideline titled "Bioequivalence for Immediate-Release Solid Oral Dosage Forms: Additional Strengths Biowaiver" that was endorsed by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Assembly in March 2025.